Tag
Diagnostics
3 articles
Dr. Lal PathLabs 32nd AGM Approves ₹4 Dividend
Dr. Lal PathLabs held its 32nd Annual General Meeting on July 25, 2026, concluding at 11:03 AM IST.
Shareholders approved a final dividend of ₹4 per share for FY ended March 31, 2026, via ordinary res
Dr Lal PathLabs Q1 Net Profit Rises 28% to ₹1.7B
Approved unaudited standalone and consolidated financial results for Q1 FY27, showing revenue growth of 19% YoY to ₹7.98B.
Declared interim dividend of ₹5 per share (50% on face value ₹10) with record
Thyrocare Q1 FY27 PAT Jumps 34% YoY
Thyrocare reported unaudited Q1 FY27 consolidated revenue of ₹240 Cr, up 24% YoY, and PAT of ₹51.33 Cr, up 34% YoY.
Operational highlights include processing 5.4 Mn patients (+17% YoY) and expanding t